For the purpose of secondary prevention of coronary heart disease, it is necessary to normalize the lipid spectrum of a patient who has had myocardial infarction. In the 90s, many randomized studies in which the role of lipid-lowering drugs (primarily the most powerful of them – statins) was studied both in slowing the progression of atherosclerosis (according to angiography or […]
Read MoreCopyright © 2019 my-pharm-blog.com